REPRIEVE trialcardiovascular diseasePitavastatinstatinQRISK
…IV (PLHIV) are at increased risk of cardiovascular disease. The REPRIEVE trial demonstrated benefits of statin therapy for all PLHIV ≥40, rega…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: REPRIEVE trial ×
REPRIEVE trial
This institution is selected. Its supporting articles are shown below.